HCA Healthcare Inc NYSE:HCA Price, Chart, News & Insight

HCA Healthcare (HCA) Stock Falls 7.1% After KeyCorp Lowers Price Target

HCA Healthcare (NYSE: HCA) shares dropped 7.1% on Tuesday after KeyCorp lowered its price target on the hospital operator to $475 from $510 while maintaining its "Overweight" rating.

The lower price target reflects a more cautious near-term valuation outlook, although KeyCorp continues to view HCA favorably relative to the broader market. By maintaining its Overweight rating, the firm signaled continued confidence in the company's long-term fundamentals despite trimming its valuation.

HCA remains one of the largest for-profit hospital operators in the United States, supported by its broad hospital network, strong cash flow generation, and consistent demand for healthcare services. However, investors have recently become more cautious toward the healthcare provider sector amid concerns over labor costs, reimbursement rates, and medical utilization trends.

The analyst action comes as hospital operators continue to balance improving patient volumes against ongoing cost pressures, including wages and operating expenses. Investors are also closely monitoring potential changes in government reimbursement policies and the broader regulatory environment.

Tuesday's decline suggests the lower price target weighed on investor sentiment despite the maintained Overweight rating. Investors will now look ahead to HCA's upcoming quarterly earnings for updates on patient volumes, operating margins, and management's outlook for the remainder of the year.

💬 🔗

The Investor 07-14-26

HCA Healthcare reported first-quarter 2026 results with revenue increasing 4.3% year-over-year to $19.1 billion.

Net income rose slightly to $1.62 billion, while earnings per share grew 10.9% to $7.15, supported by improved profitability and cost management. Adjusted EBITDA increased 1.9% to $3.8 billion, and operating cash flow rose 22% to $2.0 billion.

Patient volumes showed modest growth, though overall activity was impacted by lower respiratory-related admissions and weather disruptions. These effects were largely offset by higher reimbursement contributions, including Medicaid supplemental programs.

Source: Business Wire

💬 🔗

WS Investor 04-24-26

HCA Healthcare, Inc. 1Q 2026 Earnings Call
April 24, 2026, at 9:00 AM Central (10:00 AM Eastern)

💬 🔗

The Investor 03-26-26

HCA Healthcare announced that 44 of its hospitals were recognized on Healthgrades’ America’s 250 Best Hospitals list for 2026, highlighting strong performance in clinical outcomes across multiple specialties. Within this group, three hospitals ranked among America’s 50 Best Hospitals, placing them in the top 1% nationwide for consistent clinical excellence, while 15 hospitals were named among America’s 100 Best Hospitals, representing the top 2% in the country.

The hospitals ranked in the top 1% are Mission Hospital in Asheville, North Carolina; HCA HealthONE Sky Ridge in Lone Tree, Colorado; and HCA Florida Kendall Hospital in Miami, Florida. Mission Hospital marked its 11th consecutive year on the America’s 50 Best Hospitals list. HCA Healthcare said the recognition reflects its focus on patient-centered care, teamwork and measurable quality outcomes.

Healthgrades’ rankings are based exclusively on patient outcomes, using risk-adjusted mortality and complication rates derived from publicly available Medicare inpatient data. To qualify, hospitals must demonstrate strong performance across a broad range of conditions and procedures and sustain excellence over multiple years.

Source: Business Wire

💬 🔗

The Investor 01-29-26

HCA Healthcare reported strong fourth-quarter 2025 results, with revenues rising 6.7% year over year to $19.5 billion and net income climbing 30.6% to $1.88 billion. Diluted earnings per share increased to $8.14, supported by higher patient volumes, improved same-facility admissions, and gains from facility sales, while adjusted EBITDA grew 10.8% to $4.11 billion.

For the full year 2025, HCA posted revenues of $75.6 billion and net income of $6.78 billion, reflecting continued operational momentum. Management said investments in network expansion, workforce development, and clinical capabilities strengthened performance and positioned the company well heading into 2026.

💬 🔗

European Investor 01-27-26

HCA Healthcare Awards $4.8 Million to Support Launch of Pepperdine University’s New School of Nursing

HCA Healthcare announced a $4.8 million gift to Pepperdine University to help establish its newly launched School of Nursing within the College of Health Science. The contribution is part of HCA’s broader strategy to address the national nursing shortage by expanding education and training capacity.

Pepperdine’s School of Nursing, which opened this fall with 68 students, offers undergraduate and graduate degrees including a BSN and an Entry Level Master of Science, Clinical Nurse Leader. The funding will support the school’s new 30,000-square-foot facility in Calabasas, featuring advanced simulation labs, high-fidelity manikins, and immersive clinical environments. Students will also gain clinical experience at HCA Healthcare’s Los Robles Regional Medical Center.

HCA highlighted its ongoing investments in nursing workforce development, including major expansions at Galen College of Nursing, support for Research College of Nursing, and grants for early-exposure programs in high schools.

The partnership aims to strengthen nursing education infrastructure and help prepare future caregivers to meet growing healthcare demands.

💬 🔗

Global Finance News 12-07-25

HCA Healthcare collects nearly 20,000 pounds of medications in annual take-back effort

HCA Healthcare announced that its seventh annual “Crush the Crisis” prescription drug take-back event collected 19,846 pounds of unused or expired medications—equivalent to around 13.6 million doses. With this year’s results, the program has surpassed 108,500 pounds of collected medication since its launch in 2019.

Facilities across all 15 U.S. divisions partnered with local law enforcement to provide safe, anonymous disposal in alignment with the DEA’s National Prescription Drug Take Back Day. Top-collecting sites included HCA HealthONE Aurora (1,768 pounds) and Medical City McKinney (644 pounds).

HCA Healthcare also highlighted ongoing initiatives designed to reduce prescription misuse and improve pain management, including Enhanced Surgical Recovery programs and electronic prescribing of controlled substances.

The company operates 191 hospitals and about 2,500 care sites in the U.S. and U.K.

💬 🔗

WS Investor 11-13-25

HCA Healthcare Plans Senior Notes Offering

HCA Healthcare (NYSE: HCA) announced that its subsidiary, HCA Inc., intends to offer senior notes, with the final terms—maturity, interest rate, and principal amount—to be determined based on market conditions. Proceeds will be used for general corporate purposes, including repayment of borrowings under its $4 billion commercial paper program, and potentially to redeem all or part of its $1.5 billion 5.875% senior notes due 2026.

J.P. Morgan, Citigroup, Mizuho Securities, and Wells Fargo are acting as joint book-running managers. The offering will be made under an effective SEC shelf registration.

💬 🔗

The Investor 10-27-25

HCA Healthcare Reports 9.6% Revenue Growth and Record $6.96 EPS in Q3 2025

HCA Healthcare (NYSE: HCA) reported strong third-quarter 2025 results, with revenue rising 9.6% to $19.16 billion and net income increasing 29.4% to $1.64 billion, driven by higher patient volumes and improved pricing. Diluted earnings per share surged 42.6% to $6.96, while adjusted EBITDA climbed 18.5% to $3.87 billion.

Same-facility admissions grew 2.1%, and equivalent admissions rose 2.4%, reflecting steady patient demand. Emergency room visits were up 1.3%, inpatient surgeries rose 1.4%, and outpatient surgeries increased 1.1%. Same-facility revenue per equivalent admission advanced 6.6%, supported by pricing strength and service mix improvements.

Operating cash flow reached $4.42 billion, up from $3.52 billion a year earlier. HCA ended the quarter with $997 million in cash, $44.51 billion in total debt, and $59.75 billion in total assets. The company also invested $1.29 billion in capital expenditures and repurchased 6.51 million shares for $2.5 billion, with $3.26 billion remaining under its buyback authorization.

For the first nine months of 2025, HCA generated $56.09 billion in revenue and $4.91 billion in net income ($20.23 per share), up from $4.32 billion in the same period of 2024. The company declared a quarterly dividend of $0.72 per share, payable on December 29, 2025, to shareholders of record as of December 15, 2025.

💬 🔗

The Investor 10-25-25

HCA Healthcare and its foundation have renewed and expanded their collaboration with the American Heart Association, committing $3.9 million to the “Getting to the Heart of Stroke” initiative. The partnership, first launched in 2022, aims to strengthen links between cardiology and neurology to better prevent, diagnose, and treat strokes while addressing health disparities.

Since its launch, the initiative has reached more than 200 million people with stroke and AFib education, engaged over 160 community organizations, and improved stroke cause identification at participating hospitals by 33%. The next phase will expand quality improvements to all 43 of HCA’s comprehensive stroke centers and broaden community-based programs focused on prevention and early detection.

HCA executives emphasized the importance of advancing cardiovascular and neurological care together, while the American Heart Association said the program highlights the critical role of the heart-brain connection in stroke prevention and recovery.

💬 🔗

The Investor 09-10-25

NYSE:HCAFollow

NYSE:HCA